Details for 2021208092
Up to date per 01.04.2026
Actions
Details for 2021208092
Granted/Registered
European Patent
08.06.2022 A
28.12.2022 B1
31.08.2010
US
37883110 P
A61K 48/00 20060101AFI20220504BHEP
Owner
GlaxoSmithKline Biologicals SARue de l'Institut 89 1330 RixensartBE
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
GEALL, Andrew Emeryville, CA 94662-8097US
VERMA, Ayush Emeryville, CA 94662-8097US
Information about Fees